IP Verse

Biocon Biologics competitive analysis

Explore patent oppositions filed by Biocon Biologics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Feb 5, 2026

Patent Number	Title	Applicant	Opposition Date
EP3883606	Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody	JANSSEN BIOTECH	Apr 8, 2024

Discover the latest PTAB cases involving Biocon Biologics, highlighting their recent legal challenges and patent disputes.

Last updated on: Feb 4, 2026

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Biocon Biologics
IPR2024-00298	Dec 18, 2023	BIOCON BIOLOGICS	REGENERON PHARMACEUTICALS	Terminated-Adverse Judgment
IPR2023-01444	Nov 22, 2023	BIOCON BIOLOGICS	JANSSEN BIOTECH	Terminated-Settled
IPR2024-00201	Nov 20, 2023	BIOCON BIOLOGICS	REGENERON PHARMACEUTICALS	Terminated-Adverse Judgment

IP litigation analysis comparing Biocon Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 5, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BIOCON BIOLOGICS	1	-	3	-
JANSSEN BIOTECH	6	20	1	2
REGENERON PHARMACEUTICALS	38	94	9	31